Spots Global Cancer Trial Database for smoldering multiple myeloma (smm)
Every month we try and update this database with for smoldering multiple myeloma (smm) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer | NCT04731844 | Prostate Cancer Multiple Myelom... Smoldering Mult... Monoclonal Gamm... | Curcumin plus P... | 18 Years - | University of Rochester | |
| B-Cell Hematologic Malignancy Vaccination Registry | NCT02298816 | Monoclonal Gamm... Multiple Myelom... Waldenstrom Mac... Lymphocytosis Lymphoma, Non-H... B-Cell Chronic ... Hematological M... | - | Aurora Health Care | ||
| A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma | NCT05955508 | Smoldering Mult... | Linvoseltamab | 18 Years - | Regeneron Pharmaceuticals | |
| A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma | NCT02316106 | Multiple Myelom... | daratumumab daratumumab daratumumab | 18 Years - | Janssen Research & Development, LLC | |
| B-Cell Hematologic Malignancy Vaccination Registry | NCT02298816 | Monoclonal Gamm... Multiple Myelom... Waldenstrom Mac... Lymphocytosis Lymphoma, Non-H... B-Cell Chronic ... Hematological M... | - | Aurora Health Care | ||
| Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer | NCT02240537 | Acute Myelogeno... Multiple Myelom... Myelodysplastic... Smoldering Mult... | Sargramostim BB-MPI-03 Montanide | 18 Years - | Benovus Bio, Inc. | |
| Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer | NCT04731844 | Prostate Cancer Multiple Myelom... Smoldering Mult... Monoclonal Gamm... | Curcumin plus P... | 18 Years - | University of Rochester | |
| A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma | NCT05955508 | Smoldering Mult... | Linvoseltamab | 18 Years - | Regeneron Pharmaceuticals | |
| A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma | NCT06140524 | Monoclonal Gamm... Smoldering Mult... | Linvoseltamab | 18 Years - | Regeneron Pharmaceuticals | |
| A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma | NCT02316106 | Multiple Myelom... | daratumumab daratumumab daratumumab | 18 Years - | Janssen Research & Development, LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
